Literature DB >> 22836935

[Linkage of secondary data with cancer registry data on the basis of encrypted personal identifiers - results from a pilot study in North Rhine-Westphalia].

H Kajüter1, W U Batzler, V Krieg, O Heidinger, H-W Hense.   

Abstract

BACKGROUND: The Cancer Registry of North-Rhine-Westphalia stores exclusively encrypted personal identifiers of registered cancer patients. Therefore, comparisons with secondary data sets can only be performed by record linkage procedures that are based on encrypted personal identifiers. We report on a pilot study which linked encrypted personal data from the disease management program for patients with diabetes mellitus type 2 (DMP-DM2) with the database of the EKR NRW in order to test the feasibility and efficiency of these record linkage procedures.
METHODS: Personal identifying variables of the DMP records were encrypted in a 2-stage process before being sent electronically to the EKR NRW where they were subsequently submitted to a probabilistic record linkage with the registry data. The study included 27 450 participants who were insured at the AOK NordWest, residents of the district Münster and who were aged 40-79 years at the time of first enrolment to the DMP-DM2 between June 2003-July 2008.
RESULTS: The electronic processing time of the semi-automatic record linkage procedure took about 24 h. Approximately 2% of the records had to be reviewed manually. After exclusion of prevalent cancer cases, multiple primaries and inadequate data, 26 742 participants (47.3% men; 52.7% women) remained in the data set. About 1 364 cohort members (759 men, 605 women) were diagnosed with cancer after submission to the disease management program. DISCUSSION: The DMP-DM2 records were encrypted and linked to cancer registry data with a moderate personnel and financial input and high efficiency. Linked records were instantly usable for epidemiological analyses. Experiences of the pilot study suggest that future linkage studies can further advance the level of data protection, without losses in efficiency, by moderately complex software modifications and amendments of the data flow. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22836935     DOI: 10.1055/s-0032-1314828

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  5 in total

Review 1.  Individual Data Linkage of Survey Data with Claims Data in Germany-An Overview Based on a Cohort Study.

Authors:  Stefanie March
Journal:  Int J Environ Res Public Health       Date:  2017-12-09       Impact factor: 3.390

2.  The Incidence of Intestinal Gastric Cancer among Resettlers in Germany-Do Resettlers Remain at an Elevated Risk in Comparison to the General Population?

Authors:  Anna Lindblad; Simone Kaucher; Philipp Jaehn; Hiltraud Kajüter; Bernd Holleczek; Lauren Lissner; Heiko Becher; Volker Winkler
Journal:  Int J Environ Res Public Health       Date:  2020-12-09       Impact factor: 3.390

3.  Trauma registry record linkage: methodological approach to benefit from complementary data using the example of the German Pelvic Injury Register and the TraumaRegister DGU(®).

Authors:  Markus Burkhardt; Ulrike Nienaber; Joerg H Holstein; Ulf Culemann; Bertil Bouillon; Emin Aghayev; Thomas Paffrath; Marc Maegele; Tim Pohlemann; Rolf Lefering
Journal:  BMC Med Res Methodol       Date:  2013-03-05       Impact factor: 4.615

4.  Cancer Incidence and Mortality Among Ethnic German Migrants From the Former Soviet Union.

Authors:  Simone Kaucher; Hiltraud Kajüter; Heiko Becher; Volker Winkler
Journal:  Front Oncol       Date:  2018-09-11       Impact factor: 6.244

5.  [Linkage of claims data with data from epidemiological cancer registries: possibilities and limitations in the German federal states].

Authors:  Iris Pigeot; Brenda Bongaerts; Andrea Eberle; Alexander Katalinic; Joachim Kieschke; Sabine Luttmann; Martin Meyer; Alice Nennecke; Wolfgang Rathmann; Roland Stabenow; Heide Wilsdorf-Köhler; Bianca Kollhorst; Tammo Reinders
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-12-23       Impact factor: 1.595

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.